SAN DIEGO, May 27, 2014 /PRNewswire/ -- Volcano
Corporation (Nasdaq: VOLC), a leading developer and manufacturer of
precision guided therapy tools designed to enhance the diagnosis
and treatment of coronary and peripheral vascular disease, will
hold a conference call and webcast today to discuss its
announcement that it has signed an agreement to acquire AtheroMed,
Inc.
The conference call and webcast will begin at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time). The call can
be accessed by dialing (631) 291-4555, passcode 52083889, or via
the company's website at www.volcanocorp.com. A replay of the call
will be available through Friday, May
30, by dialing (404) 537-3406, passcode 52083889, and via
the company's website.
About Volcano Corporation
Volcano Corporation is revolutionizing the medical device
industry with a broad suite of technologies that make imaging and
therapy simpler, more informative and less invasive. Our products
empower physicians around the world with a new generation of
analytical tools that deliver more meaningful information—using
light and sound as the guiding elements. Founded in cardiovascular
care and expanding into other specialties, Volcano is changing the
assumption about what is possible in improving patient outcomes by
combining imaging and therapy together. For more information, visit
the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation